金色化物Rh2通过促进血管生成和线粒体生物能学对心肌梗塞产生治疗作用
Zikun Duan1,2, Baohong Yuan1, Hongbin Li1
1Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, No 1. Youyi Road, Yuzhong District, Chongqing 400016, China.
Journal of agricultural and food chemistry
|June 6, 2025
概括
金色化物Rh2 (Rh2) 通过改善线粒体功能和激活ERK信号来保护心肌梗塞 (MI) 后的心脏. 这种天然化合物为心脏损伤提供了潜在的治疗益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管生物学 心血管生物学
- 线粒体医学 线粒体医学
背景情况:
- 金色化物Rh2 (Rh2) 是Panax人参中的植物化学物质,具有已知的抗癌和神经保护性质.
- 现有的研究表明Rh2可能会减轻多克索鲁比诱导的心脏损伤.
- 急性心肌梗塞 (AMI) 仍然是导致死亡的主要原因,需要新的心脏保护策略.
研究的目的:
- 在急性心肌梗塞 (AMI) 的小鼠模型中评估金赛诺化物Rh2 (Rh2) 的心脏保护作用.
- 研究Rh2介导心脏保护的潜在机制,重点关注线粒体功能和信号通路.
主要方法:
- 小鼠接受了心肌梗塞 (MI) 的手术诱导,并在手术后的14天内接受了Rh2治疗.
- 评估心脏功能使用心声回声学.
- 在体外研究中使用人类静脉内皮细胞 (HUVEC) 来检查细胞迁移和ERK酸化.
主要成果:
- 在心脏病发作模型中,Rh2治疗显著改善了左心室功能,并减少了心脏病发作的大小.
- Rh2抑制了心脏纤维化,促进了血管生成,并增强了线粒体功能 (增加了膜潜力,ATP生产).
- Rh2减少了缺氧诱导的活性氧物种 (ROS) 积累,线粒体分裂和心肌细胞亡,同时通过ERK激活增强了HUVEC迁移.
结论:
- 金色化物Rh2 (Rh2) 显示出对心肌梗塞 (MI) 引起的心脏损伤的显著心脏保护作用.
- Rh2增强了线粒体的生物能量,并激活了依赖ERK的通路,从而促进了它的保护作用.
- 这些发现强调了Rh2作为治疗心脏损伤的潜在治疗剂.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
526
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
526
01:26Heart Failure Drugs: Inotropic Agents
747
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
747
01:46Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
706
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
706